Strategic Outsourcing: The Growing Trend In The Pharmaceutical Industry

By Max Horn, Managing Director at Vetter Pharma-Fertigung GbmbH & Co KG

Over the last few years, the licensing standards of regulatory authorities have grown increasingly strict and, with global competition, cost pressures have intensified. In this competitive market, technologies are obsolescing faster than ever while the demand for quality continues to rise. The need for specialised knowledge and improved quality control, coupled with soaring process costs, are driving many pharmaceutical companies to rethink their strategies. As a result, the general industrial and service outsourcing trend that began in the 1990s has finally hit the pharmaceutical industry.

Click here to download the complete article in PDF format.